Stefan Oelrich - Covid 19 vaccines - gene therapy with experimental preparations.

I always like to say that if we had conducted a public study 2 years ago, would you be willing to accept gene or cell therapy and inject it into your body, we would probably have a 95% rejection rate

The Head of the Pharmaceutical Department of Bayer, Stefan Oelrich, on 24.10.2021 at the World Summit on Healthcare and Capitalization of the Inertia of Innovation from COVID-19.